ArticleJHLT open2025
Uncharted territories on pediatric heart and lung transplant patients' health-related quality of life: A scoping review.
Article in JHLT open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although survival is good after pediatric heart transplantation (HTx) and steadily improving after pediatric lung transplantation (LTx), it remains unclear whether this also translates into a satisfactory health-related quality of life (HRQOL). Methods: This scoping review summarizes the findings on pediatric patients' overall HRQOL after HTx or LTx published in PubMed up to January 23, 2025. Data on study design, population characteristics, measurement methods, HRQOL definitions, and results are tabulated and described narratively for HTx and LTx separately. Results: Twenty-seven papers covering 24 original studies (3 qualitative and 21 quantitative) report on pediatric HTx' patients HRQOL. Most quantitative studies indicate that their HRQOL is generally good, both during childhood and into adulthood, and is comparable to that of healthy peers or children with other chronic conditions. However, the 3 qualitative studies portray more varied experiences, with the post-Tx trajectory being marked by ups and downs. Only 4 papers focus on pediatric LTx patients' HRQOL. The 2 prospective studies show a favorable HRQOL early post-Tx, while the 2 qualitative studies also report more mixed experiences. Nevertheless, studies are generally small, do not define HRQOL, use diverse measures, and exhibit substantial exclusion and refusal rates. Conclusions: While most studies present an optimistic view of pediatric patients' HRQOL, these findings should be interpreted with caution due to the methodological heterogeneity and selection bias present within the current evidence base. This review offers several directions for methodological improvement in future research, aiming to deepen our understanding of HRQOL in ALL pediatric cardiothoracic transplant patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.